Neustar Research Reveals 92% of UK Organisations Unaware of Impact DNS is Having on Internet Users
22.3.2017 08:00 | Business Wire
Neustar, Inc. (NYSE:NSR), a trusted, neutral provider of real-time information services, today released findings from new research into how UK businesses are provisioning domain name system (DNS) servers and services, finding that 92 percent have limited visibility of the impact DNS performance is having on their internet users and visitors to their online resources. Although DNS is a fundamental utility supporting the internet and relied upon by all businesses, visibility is hampered by complexity with 45 percent of organisations having as many as 8 different ways of provisioning their DNS infrastructure.
The report, titled Winning the domain game: the business case for a specialist DNS provider, commissioned from independent analysis firm, Quocirca, presents new UK-focused research into how businesses are provisioning DNS servers and services in the interests of both their internal and external internet users. The full report from Quocirca can be read here: https://hello.neustar.biz/2017-quocirca-dns-research-paper-security-lp.html
“The internet is now a core utility for all businesses, as essential as electricity and water supply. However, unlike these utilities, internet use is bi-directional; outward, for employees and other internal users to engage with the world, and inward for customers and other visitors to find an organisation’s online resources. It’s also reliant on its own fundamental utility, the domain name system or DNS,” explains Bob Tarzey, Analyst & Director, Quocirca. “At its most basic, DNS is an address book which matches websites to internet Protocol (IP) addresses. Our research reveals that many organisations have yet to realise that DNS can be so much more than that; sitting on the frontline in the online security battle, maximising use of backend resources, ensuring governance and providing a rich source of data for marketing teams.”
Key findings from interviews with 100 senior IT decision makers at UK-based businesses in a variety of sectors reveals:
- Critical Issues – 72 percent of organisations reported regularly suffering from at least one of 6 critical issues that impact website and application availability (including Distributed Denial of Service [DDoS] attacks, network access issues and web server downtime), and 61 percent revealing the same for performance – any of these ‘internet problems’ are potentially DNS-related.
- DNS Complexity – Despite being relied upon by all businesses, only 8 percent of respondents claim to have full visibility across all areas of DNS, including frequency of dropped requests, cache poisoning, latency and overall load on DNS infrastructure, rendering it impossible to ensure a consistent service to internal and external Internet users. DNS complexity is a major reason for lack of visibility with 45 percent of organisations having as many as 8 different ways of provisioning their infrastructure.
- Room for improvement – 89 percent of respondents claim to be using a specialist DNS service provider, but just 15 percent have committed to using it for both internal and external DNS purposes to provide advanced features such as mitigation against DDoS attacks, reducing infrastructure load and central management tools to improve visibility. With so few benefiting from advanced features, it would suggest a lack of knowledge about the value add that can be provided via DNS, and what could be achieved by using a specialist DNS service provider.
When complexity starts to prevent the delivery of efficiency and security benefits, businesses need to sit up and take notice. The report found that the majority of organisations use ISPs, managed hosting providers and internet registrars as way of provisioning some of their DNS needs. Such suppliers provide DNS services as a spinoff from the other things they do. On the other hand, 92 percent of organisations polled maintain some in-house DNS capability to cover recursive DNS (for internal internet users) and/or authoritative DNS (for external internet users) requirements. However, this unfocused approach to DNS management has its own drawbacks. Advanced DNS provision and management, as performed by a specialist DNS service provider, can deliver a number of valuable features to address these issues and provide significant value-add for businesses.
“DNS has been called the most important part of the internet that people don’t know about and its time IT managers woke up to what a professional DNS service can deliver to business,” said Rodney Joffe, SVP and Fellow at Neustar. “As the report highlights, DNS can be so much more than a website address directory. Provisioned correctly, by a reputable specialist DNS service provider, it can defend the frontline in the fight against cyber-attacks, maximise the use of backend resources, ensure governance and be a rich source of marketing data.”
Every day, the world generates roughly 2.5 quadrillion bits of data. Neustar (NYSE: NSR) isolates certain elements and analyzes, simplifies and edits them to make precise and valuable decisions that drive results. As one of the few companies capable of knowing with certainty who’s on the other end of every interaction, we’re trusted by the world’s great brands to make critical decisions some 20bn times a day. We help marketers send timely and relevant messages to the right people. Because we can authoritatively tell a client exactly who is calling or connecting with them, we make critical realtime responses possible. And the same comprehensive information that enables our clients to direct and manage orders also stops attackers. We know when someone isn’t who they claim to be, which helps stop fraud and denial of service before they’re a problem. Because we’re also an experienced manager of some of the world’s most complex databases, we help clients control their online identity, registering and protecting their domain name, and routing traffic to the correct network address. By linking essential information with people who depend on it, we provide 11,000+ clients worldwide with decisions—not just data.
+44 207 559 5632
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 20:15 | Pressemelding
Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 20:11 | Pressemelding
Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy
European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25 | Pressemelding
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the
IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00 | Pressemelding
IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman
PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03 | Pressemelding
PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate
Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00 | Pressemelding
Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom